Liu H - Search Results

1

Dapagliflozin targets SGLT2/SIRT1 signaling to attenuate the osteogenic transdifferentiation of vascular smooth muscle cells.

Li L, Liu H, Chai Q, Wei J, Qin Y, Yang J, Liu H, Qi J, Guo C, Lu Z. Li L, et al. Among authors: liu h. Cell Mol Life Sci. 2024 Nov 9;81(1):448. doi: 10.1007/s00018-024-05486-8. Cell Mol Life Sci. 2024. PMID: 39520538 Free PMC article.

2

Dapagliflozin Suppresses Isoprenaline-Induced Cardiac Hypertrophy Through Inhibition of Mitochondrial Fission.

Yang ZJ, Guo CL, Gong YX, Li L, Wang LL, Liu HM, Cao JM, Lu ZY. Yang ZJ, et al. J Cardiovasc Pharmacol. 2024 Feb 1;83(2):193-204. doi: 10.1097/FJC.0000000000001518. J Cardiovasc Pharmacol. 2024. PMID: 38030139 Free PMC article.

3

Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.

Lu ZY, Qi J, Yang B, Cao HL, Wang RY, Wang X, Chi RF, Guo CL, Yang ZM, Liu HM, Li B. Lu ZY, et al. Cardiovasc Drugs Ther. 2020 Oct;34(5):605-618. doi: 10.1007/s10557-020-07000-1. Cardiovasc Drugs Ther. 2020. PMID: 32564303

4

Angiotensin-(1-9) prevents angiotensin II-induced endothelial apoptosis through CNPY2/PERK pathway.

Guo CL, Liu HM, Li B, Lu ZY. Guo CL, et al. Apoptosis. 2023 Apr;28(3-4):379-396. doi: 10.1007/s10495-022-01793-2. Epub 2022 Nov 22. Apoptosis. 2023. PMID: 36422742

5

Correction: Angiotensin-(1-9) prevents Angiotensin II-induced endothelial apoptosis through CNPY2/PERK pathway.

Guo CL, Liu HM, Li B, Lu ZY. Guo CL, et al. Apoptosis. 2023 Oct;28(9-10):1496-1499. doi: 10.1007/s10495-023-01876-8. Epub 2023 Jul 20. Apoptosis. 2023. PMID: 37470918 No abstract available.

6

Association of angiogenesis-associated genes with atherosclerotic plaque progression, intraplaque hemorrhage, and immune infiltration.

Chai Q, Guo C, Li L, Cao J, Liu H, Lu Z. Chai Q, et al. Among authors: liu h. Heliyon. 2024 Jun 7;10(12):e32692. doi: 10.1016/j.heliyon.2024.e32692. eCollection 2024 Jun 30. Heliyon. 2024. PMID: 39183847 Free PMC article.

7

Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy.

Liu HM, Guo CL, Zhang YF, Chen JF, Liang ZP, Yang LH, Ma YP. Liu HM, et al. Front Pharmacol. 2021 Apr 16;12:657724. doi: 10.3389/fphar.2021.657724. eCollection 2021. Front Pharmacol. 2021. PMID: 33935775 Free PMC article.

8

Hydrogen Sulfide Diminishes Activation of Adventitial Fibroblasts Through the Inhibition of Mitochondrial Fission.

Lu ZY, Guo CL, Yang B, Yao Y, Yang ZJ, Gong YX, Yang JY, Dong WY, Yang J, Yang HB, Liu HM, Li B. Lu ZY, et al. J Cardiovasc Pharmacol. 2022 Jun 1;79(6):925-934. doi: 10.1097/FJC.0000000000001250. J Cardiovasc Pharmacol. 2022. PMID: 35234738 Free PMC article.

9

Effect of Diallyl Trisulfide on Ischemic Tissue Injury and Revascularization in a Diabetic Mouse Model.

Yang HB, Liu HM, Yan JC, Lu ZY. Yang HB, et al. J Cardiovasc Pharmacol. 2018 Jun;71(6):367-374. doi: 10.1097/FJC.0000000000000579. J Cardiovasc Pharmacol. 2018. PMID: 29642134 Free PMC article.

10

Diallyl trisulfide attenuates hyperglycemia-induced endothelial apoptosis by inhibition of Drp1-mediated mitochondrial fission.

Hao Y, Liu HM, Wei X, Gong X, Lu ZY, Huang ZH. Hao Y, et al. Acta Diabetol. 2019 Nov;56(11):1177-1189. doi: 10.1007/s00592-019-01366-x. Epub 2019 May 21. Acta Diabetol. 2019. PMID: 31115753 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

95,678 results

Search Page

Filters